We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
In cooperation with Association of Corporate Counsel
  Request new password

Search results

Order by most recent / most popular / relevance

Results: 1-10 of 78

April vote scheduled before EU Parliament on clinical trial data accessibility

  • Shook Hardy & Bacon LLP
  • -
  • European Union
  • -
  • March 20 2014

The European Parliament has postponed until April 2, 2014, debate on amended draft legislation (20120192 (COD)) that would require phar- maceutical

WHOEU warns that overweight children becoming a “new norm”

  • Shook Hardy & Bacon LLP
  • -
  • European Union, Global
  • -
  • February 28 2014

The World Health Organization's Regional Office for Europe (WHOEU) reportedly warned attendees of a February 25-26, 2014, health conference held by

EFSA announces public consultation on niacin

  • Shook Hardy & Bacon LLP
  • -
  • European Union, USA
  • -
  • February 20 2014

At the request of the European Commission, the European Food Safety Authority (EFSA) has launched a public consultation on draft guidance issued by

Public-private EU partnership to fund stem cell banking and distribution

  • Shook Hardy & Bacon LLP
  • -
  • European Union
  • -
  • February 13 2014

A consortium of public and private partners has reportedly formed to establish a European induced pluripotent stem (iPS) cell bank with the goal of

European markets less than enthusiastic over biosimilars

  • Shook Hardy & Bacon LLP
  • -
  • European Union, USA
  • -
  • December 12 2013

While Europe has had a regulatory approval pathway for biosimilar drug products for some years, their use reportedly remains anemic. Physicians are

FSA-commissioned study examines aspartame’s alleged health effects

  • Shook Hardy & Bacon LLP
  • -
  • European Union
  • -
  • December 6 2013

The U.K. Committee on Toxicity of Chemicals in Food, Consumer Products and the Environment (COT) has released a December 2013 position paper on the

R&D for new drugs to treat “neglected diseases” continues to lag

  • Shook Hardy & Bacon LLP
  • -
  • European Union
  • -
  • October 31 2013

European researchers writing in a medical journal have found that just 4 percent of new therapeutic products registered with drug regulatory

EC seeks data on nanomaterials in agri-food-feed

  • Shook Hardy & Bacon LLP
  • -
  • European Union
  • -
  • October 18 2013

The European Commission-Joint Research Centre and Institute of Food Safety of the University of Wageningen in The Netherlands, at the request of the

Argan powder linked to occupational asthma

  • Shook Hardy & Bacon LLP
  • -
  • European Union
  • -
  • September 12 2013

A small study, presented September 9, 2013, at the European Respiratory Society Annual Congress in Barcelona, has reportedly revealed that argan

EU to review non-animal skin allergen test

  • Shook Hardy & Bacon LLP
  • -
  • European Union
  • -
  • August 15 2013

According to news sources, a new, non-animal skin testing method will be submitted to the European Union (EU) Reference Laboratory for alternatives